MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Country |
 Schweiz |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
91.6 M |
Market Cap[1] |
$ 1.1 M |
EBITDA (LTM) |
$ -209 M |
P/E (LTM) |
- |
P/S (LTM) |
0.02 |
EPS (LTM) |
-71.8 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
$ 110.24 | -2.86 % | $ 33.5 B | NYSE,SPB |  USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Waters Corporation
WAT
|
$ 289.16 | -3.79 % | $ 17.2 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 2.68 | -3.94 % | $ 57.8 M | Nasdaq Global Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.36 | -11.57 % | $ 176 M | Nasdaq Global Market |  China |
 |
Sotera Health Company
SHC
|
$ 13.13 | -3.03 % | $ 3.73 B | Nasdaq Global Select Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
BioNano Genomics
BNGO
|
$ 1.16 | 0.87 % | $ 6.32 M | Nasdaq Capital Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
DexCom
DXCM
|
$ 62.25 | -5.81 % | $ 24.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 23.53 | -4.74 % | $ 654 M | Nasdaq Global Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 159.16 | -3.62 % | $ 7.89 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 195.51 | -1.33 % | $ 21.7 B | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.68 | -2.89 % | $ 7.37 M | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Neogen Corporation
NEOG
|
$ 8.7 | -4.92 % | $ 1.89 B | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 264.2 | -1.56 % | $ 22 B | NYSE,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Precipio
PRPO
|
$ 25.97 | -4.52 % | $ 33.7 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 16.78 | -3.95 % | $ 894 M | Nasdaq Global Market,SPB | USA |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | Britain |
 |
VolitionRx Limited
VNRX
|
$ 0.2 | 1.87 % | $ 19.2 M | NYSE American |  Singapore |
 |
Bioventus
BVS
|
$ 8.94 | -3.46 % | $ 596 M | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Danaher Corporation
DHR
|
$ 181.52 | -3.27 % | $ 129 B | NYSE,SPB | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.29 | -6.54 % | $ 2.3 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.